secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tarsus Pharmaceuticals, Inc. (TARS)
CIK:        0001819790
Form:       8-K
Filed at:   2023-08-02T23:59:59+00:00
Accession:  0001193125-23-201717
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tarsus prices $100M public offering of 5.71M shares at $17.50/share
-------------------------------------------------------------------

- Net proceeds expected to be ~$93.6M after underwriting discounts and offering expenses.
- Underwriters granted 30-day option to purchase up to an additional 857,142 shares.
- Joint book-running managers: Goldman Sachs, BofA Securities, Guggenheim Securities, Oppenheimer.
- Offering expected to close on August 4, 2023, subject to customary closing conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819790/000119312523201717/0001193125-23-201717-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819790/000119312523201717/d596862d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-201717

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer